Antioxidant Cell Culture Media for Lower Polypeptide Color

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing cell culture methods struggle to produce therapeutic proteins with acceptable color intensity and concentration, particularly for subcutaneous delivery, due to oxidation of amino acids and unclear impact of culture conditions on color intensity.

Innovation Solution

Incorporating hypotaurine or its analogs into cell culture media reduces the color intensity of polypeptides by up to 50% through the use of specific concentrations, maintaining desired protein concentrations and quality attributes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If cell culture parameters are optimized for improving productivity of the protein product, then protein production concentration is improved, but color intensity increases due to oxidation of amino acids

Engineering Contradiction:
Improveprotein production concentrationVSAvoidcolor intensity
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent introduces antioxidants (vitamin C, vitamin E, or a combination thereof) as intermediary substances that mediate between the high protein concentration required for productivity and the oxidation damage that causes color intensity. These antioxidants act as protective agents that prevent direct oxidation of amino acids while allowing high protein production to proceed.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the chemical environment parameters of the cell culture medium by adding specific antioxidant compounds at defined concentrations. This parameter change modifies the oxidative stress conditions during protein production, enabling high productivity to be achieved without the corresponding increase in color intensity that would normally occur.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If antioxidant concentrations are increased to reduce color intensity, then color intensity is reduced, but cell culture medium complexity increases

Engineering Contradiction:
Improvecolor intensityVSAvoidcell culture medium complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent optimizes the concentration parameters of antioxidants in the cell culture medium, establishing specific ranges (e.g., vitamin C at 0.01-10 mM, vitamin E at 0.01-10 µM) that provide effective color intensity reduction without excessive complexity. These parameter optimizations balance protective effects with medium simplicity.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method effectively lowers the color intensity of polypeptides produced by cells cultured in media containing hypotaurine or its analogs, ensuring compliance with regulatory standards and enhancing the quality of therapeutic protein formulations.

Implementation Method 1

Oxidation is a major chemical degradation pathway for protein pharmaceuticals. For example, methionine, cysteine, histidine, tryptophan, and tyrosine are amino acid residues that are susceptible to oxidation due to their reactivity with reactive oxygen species (ROS)

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS20260008997A1Cell culture compositions with antioxidants and methods for polypeptide production
Publication Date: 2026.01.08 GENENTECH INC
  • US20260008997A1 patent drawing
  • US20260008997A1 patent drawing
  • US20260008997A1 patent drawing

AI summary

Cell culture media comprising antioxidants are provided herein as are methods of using the media for cell culturing and polypeptide production from cells. Compositions comprising polypeptides, such as therapeutic polypeptides, produced by the methods herein are also provided.